Manu Diagnostic Centre & Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-12-2024
- Paid Up Capital ₹ 0.50 M
as on 24-12-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
as on 24-12-2024
- Revenue 75.07%
(FY 2022)
- Profit 620.46%
(FY 2022)
- Ebitda 133.30%
(FY 2022)
- Net Worth 10.85%
(FY 2022)
- Total Assets 23.75%
(FY 2022)
About Manu Diagnostic Centre & Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.50 M.
Ramesh Mukkannavar, Avinash Mukkanawar, and Bhuvneshwari serve as directors at the Company.
- CIN/LLPIN
U85110HP2012PTC000222
- Company No.
000222
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Kullu, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Manu Diagnostic Centre & Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Mukkannavar  | Managing Director | 30-Aug-2012 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Avinash Mukkanawar | Director | 22-Jul-2013 | Current |
| Bhuvneshwari | Director | 29-Aug-2024 | Current |
Financial Performance of Manu Diagnostic Centre & Hospital.
Manu Diagnostic Centre & Hospital Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 75.07% increase. The company also saw a substantial improvement in profitability, with a 620.46% increase in profit. The company's net worth Soared by an impressive increase of 10.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manu Diagnostic Centre & Hospital?
In 2017, Manu Diagnostic Centre & Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 23 Nov 2012 | ₹1.50 M | Open |
How Many Employees Work at Manu Diagnostic Centre & Hospital?
Unlock and access historical data on people associated with Manu Diagnostic Centre & Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manu Diagnostic Centre & Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manu Diagnostic Centre & Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
